These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 25062866)
1. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Gabal YM; Kamel AO; Sammour OA; Elshafeey AH Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866 [TBL] [Abstract][Full Text] [Related]
2. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics. Wavikar P; Pai R; Vavia P J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321 [TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498 [TBL] [Abstract][Full Text] [Related]
4. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin. Fahmy UA; Ahmed OAA; Badr-Eldin SM; Aldawsari HM; Okbazghi SZ; Awan ZA; Bakhrebah MA; Alomary MN; Abdulaal WH; Medina C; Alhakamy NA Int J Nanomedicine; 2020; 15():5253-5264. PubMed ID: 32801690 [TBL] [Abstract][Full Text] [Related]
5. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded Mathure D; Ranpise H; Awasthi R; Pawar A Assay Drug Dev Technol; 2022 Jul; 20(5):211-224. PubMed ID: 35771865 [TBL] [Abstract][Full Text] [Related]
6. Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery. Wavikar PR; Vavia PR J Liposome Res; 2015; 25(2):141-9. PubMed ID: 25203610 [TBL] [Abstract][Full Text] [Related]
7. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J; Pathak A; Kishore R; Chauhan MK Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934 [TBL] [Abstract][Full Text] [Related]
8. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer. Devkar TB; Tekade AR; Khandelwal KR Colloids Surf B Biointerfaces; 2014 Oct; 122():143-150. PubMed ID: 25033434 [TBL] [Abstract][Full Text] [Related]
9. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Sharma S; Lohan S; Murthy RS Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649 [TBL] [Abstract][Full Text] [Related]
10. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers for the topical delivery of tretinoin. Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827 [TBL] [Abstract][Full Text] [Related]
12. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Tsai MJ; Wu PC; Huang YB; Chang JS; Lin CL; Tsai YH; Fang JY Int J Pharm; 2012 Feb; 423(2):461-70. PubMed ID: 22193056 [TBL] [Abstract][Full Text] [Related]
13. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Noor NM; Sheikh K; Somavarapu S; Taylor KMG Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472 [TBL] [Abstract][Full Text] [Related]
16. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
17. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
18. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate. Abdelbary G; Haider M Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084 [TBL] [Abstract][Full Text] [Related]
19. Quercetin-Loaded Nanostructured Lipid Carrier In Situ Gel for Brain Targeting Through Intranasal Route: Formulation, In Vivo Pharmacokinetic and Pharmacodynamic Studies. Sonawane D; Pokharkar V AAPS PharmSciTech; 2024 Feb; 25(2):30. PubMed ID: 38316672 [TBL] [Abstract][Full Text] [Related]